Trial Profile
Defining a Personalized Hypoxic Radiation Target Through Correlation of Functional F18-FAZA PET Imaging to Pimonidazole-stained 3D Whole-mounted Histological Specimen
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 25 Oct 2021
Price :
$35
*
At a glance
- Drugs Pimonidazole (Primary)
- Indications Squamous cell cancer; Tongue cancer
- Focus Diagnostic use
- Acronyms FAITH
- 20 Oct 2021 Planned End Date changed from 30 Jun 2021 to 30 Jun 2024.
- 20 Oct 2021 Planned primary completion date changed from 30 Dec 2020 to 30 Dec 2023.
- 09 Jul 2020 Planned End Date changed from 30 Jun 2020 to 30 Jun 2021.